DocGo, Inc.

USDC – Southern District of New York

November 15, 2023

Class Period: 11/8/2022 – 9/17/2023
Lead Plaintiff Deadline: December 26,2023

Principle Contacts

Pamela Mayer

PMayer@kaplanfox.com

Laurence D. King

LKing@kaplanfox.com

DocGo INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies DocGo Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of investors that purchased or otherwise acquired DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) securities between November 8, 2022 and September 17, 2023, inclusive (the “Class Period”). Click Here to Join Investigation.  

If you acquired DocGo securities during the Class Period and would like to discuss this case, please click here. You may also contact us by emailing pmayer@kaplanfox.com or calling (646) 315-9003.

If you are a member of the proposed Class, you may move the court no later than December 26, 2023 to serve as a lead plaintiff for the purported class.  If you have losses, we encourage you to contact us to learn more about the lead plaintiff process.

DocGo offers mobile health and medical transportation services for various healthcare providers in the U.S. and the United Kingdom. In the spring of 2023 to oversee its migrant relocation program, New York City awarded DocGo a no-bid $42 million contract (the “Relocation Contract”) that took effect in early May 2023.

On July 20, 2023, the New York Times published an article indicating a “rocky” start to DocGo’s migrant relocation efforts in New York City.  Following publication of this article, DocGo’s stock price fell $0.53 per share, or 6.29%.  Then, on August 22, 2023, the Albany Times Union published an article reporting that the New York Attorney General had opened an investigation into DocGo.  Then, on September 6, 2023 New York City Comptroller Brad Lander announced that he was declining to approve the Relocation Contract.  Mayor Adams had the authority to proceed with the Relocation Contract over Comptroller Lander’s objections and ultimately did so. On this news, DocGo’s stock price fell $0.61 per share, or 7.47%.  Then, following the Albany Times Union publication of an article on September 14, 2023 that CEO Capone had falsified portions of his professional biography and his resignation as CEO the following day, DocGo’s stock price fell 0.76 per share, or 11.76%. Finally, on September 18, 2023, Comptroller Lander announced that his office was commencing a real-time audit of operations and invoices incurred by DocGo in connection with the Relocation Contract and on this news DocGo’s stock price fell $0.41 per share or 7.19%.

The Complaint alleges that throughout the Class Period, the Company made false and/or misleading statements and/or failed to disclose that; (1) DocGo’s executive hiring processes were inadequate to fully review and vet the professional and academic backgrounds of job candidates; (the increase the likelihood of disruptive executive turnover;  (iii) contrary to its representations to investors, DocGo had overstated the efficacy of its mobile health and medical transportation services, the very services contemplated by the Relocation Contract; and when revealed , this was likely to subject DocGo to significant reputational and/or regulatory scrutiny that would negatively impact the Company’s financial position and/or prospects; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times. 

WHY CONTACT KAPLAN FOX

Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.  With over 50 years of experience in complex litigation, Kaplan Fox offers the professional experience and track record that clients demand.  Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.  For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

If you have any questions about this Notice, your rights, or your interests, please contact:

Pamela Mayer
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003
E-mail: pmayer@kaplanfox.com

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax:  (415) 772-4707
E-mail: lking@kaplanfox.com